$10 M for Inne’s Hormone Tracking Tech

A device that tells women whether they are currently fertile or not is the product developed by founder Eirini Rapti and a team of scientists. It works by analyzing spittle, because “hormones in your saliva accurately reflect the hormones in your body”, and is sold under the brand name Inne. The company is attempting to register its product as a contraceptive. Partners include the prestigious Max Delbrueck Center for Molecular Medicine. Now, as business insider reports, Inne has gained $10 M in funding.